Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? - Rotondo Dottore, G.; Ionni, I.; Menconi, F.; Casini, G.; Sellari-Franceschini, S.; Nardi, M.; Vitti, P.; Marcocci, C.; Marinò, M. (Journal of endocrinological investigation, 2018)
Keywords: Antioxidants; Antioxidants - pharmacology; Ascorbic acid; Cell growth; Cell proliferation; Cell Proliferation - drug effects; Cells, Cultured; Cysteine; Cytokines - metabolism; Cytotoxicity; Endocrinology; Female; Fibroblasts; Fibroblasts - cytology; Fibroblasts - drug effects; Fibroblasts - metabolism; Glutathione; Graves Ophthalmopathy - drug therapy; Graves Ophthalmopathy - metabolism; Graves Ophthalmopathy - pathology; Humans; Hyaluronic acid; Hyaluronic Acid - metabolism; Hydrogen peroxide; Interleukin 1; Male; Medicine; Medicine & Public Health; Melatonin; Metabolic Diseases; Middle Aged; N-Acetyl-L-cysteine; Original Article; Oxidative stress; Oxidative Stress - drug effects; Patients; Reactive Oxygen Species - metabolism; Tumor necrosis factor-α; Vitamin C; γ-Interferon; Ophthalmopathy; Melatonin; Graves; Orbitopathy; Vitamin C; cysteine; Antioxidant; acetyl; Fibroblast; N-acetyl-L-cysteine